We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Stem Cell Transplants Cure Incontinence

By HospiMedica staff writers
Posted on 12 Jun 2006
Stem cell transplantation can end incontinence caused by age or surgery, according to new research. More...


Scientists at the University of Innsbruck (Austria) took adult stem cells from a muscle biopsy, isolated myoblasts and fibroblasts from the biopsy material, and grew them in culture. When there were enough cells, the autologous fibroblasts were injected into the wall of critical sphincter muscles around the urethra to create scaffolding for the myoblasts that were also injected into the area.

The cells then performed their muscular tasks, giving new strength to the sphincters. The sphincter walls contracted better and the thickness of the urethra increased, as did the thickness of the rhambdosphincter. Incontinence scores and quality of life were improved. The procedure was performed in186 people, 123 of them women. Of that group, 156 were cured of incontinence. The results were reported at the American Urological Association (AUA) annual meeting in May 2006 in Atlanta (GA, USA).

"There have been more than a hundred proposed treatments for incontinence in these individuals,” said Hannes Strasser, M.D, "but all of them have limitations. The use of a person's own adult stem cells appears to overcome ethical issues regarding embryonic cells and, more importantly, they seem to work.”

Stem cell therapy is a part of a group of new techniques or technologies that rely on replacing diseased or dysfunctional cells with healthy, functioning ones. These new techniques are being applied experimentally to a wide range of human disorders, including many types of cancer, neurologic diseases such as Parkinson's disease and ALS (Lou Gehrig's disease), spinal cord injuries, and diabetes.



Related Links:
University of Innsbruck

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.